Home › Compare › SYRVF vs ABBV
SYRVF yields 3.30% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, SYRVF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYRVF + ABBV for your $10,000?
Sacyr, S.A. engages in the construction and infrastructure concession services businesses worldwide. The company operates through Concessions, Engineering and Infrastructure, and Services divisions. It offers various construction services comprising civil engineering and buildings, as well as engineering and construction, and maintenance of industrial and oil and gas facilities. The company also engages in motorway, transport hub, airport, and hospital concessions business. In addition, it develops conventional and renewable energy facilities, photovoltaic and geothermal plants, and biomass energy systems; maintains power plants and industrial facilities; and designs, constructs, and operates waste treatment and waste-to-power plants, as well as manages processing plants and equipment. Further, the company engages in the implementation of refinery, chemical and petrochemical, gas handling and treatment, and liquefied natural gas projects; transportation and storage of fuels; and engineering development and construction of high-voltage electricity lines and electricity substations, as well as maintenance of medium and high-voltage electricity lines. Additionally, it offers environmental work and regeneration services; integrated water cycle management, water purification, desalination, and recycling services; facility management and maintenance, building cleaning, and ancillary services; and mining services, as well as involved in street cleaning; waste collection; sludge treatment; gardening and maintenance of green areas; parking meter management; towing; bicycle rental; and removal of vehicles from public thoroughfares. Sacyr, S.A. also engages in real estate development activities; the provision of catering services; and the operation of restaurants and hotels, petrol stations, and retail outlets. The company was formerly known as Sacyr Vallehermoso S.A. and changed its name to Sacyr, S.A. in August 2013. Sacyr, S.A. is headquartered in Madrid, Spain.
Full SYRVF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.